Spatial Reconstruction of the Early Hepatic Transcriptomic Landscape after an Acetaminophen Overdose using Single-cell RNA Sequencing.
暂无分享,去创建一个
[1] H. Jaeschke,et al. Mitochondrial Protein Adduct and Superoxide Generation are Prerequisites for Early Activation of c-Jun N-terminal Kinase within the Cytosol after an Acetaminophen Overdose in Mice. , 2020, Toxicology letters.
[2] B. Sosa-Pineda,et al. Metabolic and non-metabolic liver zonation is established non-synchronously and requires sinusoidal Wnts , 2020, eLife.
[3] Bret Duffin,et al. Reproducibility across single-cell RNA-seq protocols for spatial ordering analysis , 2019, PloS one.
[4] Dominic Grün,et al. A Human Liver Cell Atlas reveals Heterogeneity and Epithelial Progenitors , 2019, Nature.
[5] Fabian J Theis,et al. Current best practices in single‐cell RNA‐seq analysis: a tutorial , 2019, Molecular systems biology.
[6] Alireza Hadj Khodabakhshi,et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.
[7] S. Itzkovitz,et al. Spatial sorting enables comprehensive characterization of liver zonation , 2019, Nature Metabolism.
[8] H. Jaeschke,et al. Mito-tempo protects against acute liver injury but induces limited secondary apoptosis during the late phase of acetaminophen hepatotoxicity , 2018, Archives of Toxicology.
[9] Abdel-latif Seddek,et al. Hepatic zonation of toxic metabolite formation: perspectives of matrix-assisted laser desorption mass spectrometry imaging , 2018, Archives of Toxicology.
[10] L. Kuepfer,et al. Spatio-temporal visualization of the distribution of acetaminophen as well as its metabolites and adducts in mouse livers by MALDI MSI , 2018, Archives of Toxicology.
[11] H. Jaeschke,et al. Mitochondrial dysfunction as a mechanism of drug-induced hepatotoxicity: current understanding and future perspectives , 2018, Journal of clinical and translational research.
[12] Paul Hoffman,et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.
[13] H. Jaeschke,et al. Mechanisms of acetaminophen hepatotoxicity and their translation to the human pathophysiology , 2017, Journal of clinical and translational research.
[14] H. Jaeschke,et al. Mitochondria-targeted antioxidant Mito-Tempo protects against acetaminophen hepatotoxicity , 2016, Archives of Toxicology.
[15] I. Amit,et al. Single-cell spatial reconstruction reveals global division of labor in the mammalian liver , 2016, Nature.
[16] H. Jaeschke,et al. Oxidative stress during acetaminophen hepatotoxicity: Sources, pathophysiological role and therapeutic potential , 2016, Redox biology.
[17] R. Stewart,et al. Single-cell RNA-seq reveals novel regulators of human embryonic stem cell differentiation to definitive endoderm , 2016, Genome Biology.
[18] William M. Lee,et al. Outcomes in Adults With Acute Liver Failure Between 1998 and 2013 , 2016, Annals of Internal Medicine.
[19] Mitchell R. McGill,et al. Mitochondrial protein adducts formation and mitochondrial dysfunction during N-acetyl-m-aminophenol (AMAP)-induced hepatotoxicity in primary human hepatocytes. , 2015, Toxicology and applied pharmacology.
[20] Mitchell R. McGill,et al. Lower susceptibility of female mice to acetaminophen hepatotoxicity: Role of mitochondrial glutathione, oxidant stress and c-jun N-terminal kinase. , 2014, Toxicology and applied pharmacology.
[21] Hartmut Jaeschke,et al. Plasma and liver acetaminophen-protein adduct levels in mice after acetaminophen treatment: dose-response, mechanisms, and clinical implications. , 2013, Toxicology and applied pharmacology.
[22] F. Gonzalez,et al. Peroxisome proliferator‐activated receptor alpha induction of uncoupling protein 2 protects against acetaminophen‐induced liver toxicity , 2012, Hepatology.
[23] T. Quinn,et al. Endogenous interleukin-4 regulates glutathione synthesis following acetaminophen-induced liver injury in mice. , 2012, Chemical research in toxicology.
[24] L. MacMillan-Crow,et al. Acetaminophen-Induced Hepatotoxicity in Mice Occurs with Inhibition of Activity and Nitration of Mitochondrial Manganese Superoxide Dismutase , 2011, Journal of Pharmacology and Experimental Therapeutics.
[25] H. Jaeschke,et al. The impact of partial manganese superoxide dismutase (SOD2)-deficiency on mitochondrial oxidant stress, DNA fragmentation and liver injury during acetaminophen hepatotoxicity. , 2011, Toxicology and applied pharmacology.
[26] H. Jaeschke,et al. c-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity. , 2010, Toxicology and applied pharmacology.
[27] C. Zwingmann,et al. Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N‐acetylcysteine , 2010, Hepatology.
[28] Neil Kaplowitz,et al. Role of JNK Translocation to Mitochondria Leading to Inhibition of Mitochondria Bioenergetics in Acetaminophen-induced Liver Injury* , 2008, Journal of Biological Chemistry.
[29] K. Jungermann,et al. Functional Hepatocellular Heterogeneity , 2007, Hepatology.
[30] M. Bonin,et al. Differential gene expression in periportal and perivenous mouse hepatocytes , 2006, The FEBS journal.
[31] N. Kaplowitz,et al. c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity. , 2006, Gastroenterology.
[32] H. Jaeschke,et al. Peroxynitrite-Induced Mitochondrial and Endonuclease-Mediated Nuclear DNA Damage in Acetaminophen Hepatotoxicity , 2005, Journal of Pharmacology and Experimental Therapeutics.
[33] H. Jaeschke,et al. Acetaminophen-induced oxidant stress and cell injury in cultured mouse hepatocytes: protection by N-acetyl cysteine. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[34] L. James,et al. Effect of N-acetylcysteine on acetaminophen toxicity in mice: relationship to reactive nitrogen and cytokine formation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[35] H. Jaeschke,et al. Peroxynitrite Is a Critical Mediator of Acetaminophen Hepatotoxicity in Murine Livers: Protection by Glutathione , 2002, Journal of Pharmacology and Experimental Therapeutics.
[36] J. Hinson,et al. Vascular and hepatocellular peroxynitrite formation during acetaminophen toxicity: role of mitochondrial oxidant stress. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.
[37] Hans van Dam,et al. Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis , 2001, Oncogene.
[38] J. Corton,et al. Peroxisome proliferator-activated receptor alpha-null mice lack resistance to acetaminophen hepatotoxicity following clofibrate exposure. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[39] J. Carbone,et al. The PPAR activator docosahexaenoic acid prevents acetaminophen hepatotoxicity in male CD-1 mice. , 1999, Journal of toxicology and environmental health. Part A.
[40] C. V. Smith,et al. Inhibition of carbamyl phosphate synthetase-I and glutamine synthetase by hepatotoxic doses of acetaminophen in mice. , 1997, Toxicology and applied pharmacology.
[41] Steven D. Cohen,et al. Protection against Acetaminophen Hepatotoxicity by a Single Dose of Clofibrate: Effects on Selective Protein Arylation and Glutathione Depletion , 1996 .
[42] Steven D. Cohen,et al. Identification of the mouse liver 44-kDa acetaminophen-binding protein as a subunit of glutamine synthetase. , 1995, Toxicology and applied pharmacology.
[43] P. Moldéus,et al. Zonation of acetaminophen metabolism and cytochrome P450 2E1-mediated toxicity studied in isolated periportal and perivenous hepatocytes. , 1993, Biochemical pharmacology.
[44] I. Calder,et al. Peroxisome proliferators protect against paracetamol hepatotoxicity in mice. , 1992, Biochemical pharmacology.
[45] A. Moorman,et al. Hepatocellular heterogeneity in ammonia metabolism: demonstration of limited colocalization of carbamoylphosphate synthetase and glutamine synthetase. , 1991, European journal of cell biology.
[46] T J Bucci,et al. Immunohistochemical localization and quantification of the 3-(cystein-S-yl)-acetaminophen protein adduct in acetaminophen hepatotoxicity. , 1991, The American journal of pathology.
[47] M. Tirmenstein,et al. Subcellular binding and effects on calcium homeostasis produced by acetaminophen and a nonhepatotoxic regioisomer, 3'-hydroxyacetanilide, in mouse liver. , 1989, The Journal of biological chemistry.
[48] K. Lindros,et al. Glutathione replenishment capacity is lower in isolated perivenous than in periportal hepatocytes. , 1988, The Biochemical journal.
[49] A. Y. Lu,et al. N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[50] R. Gebhardt,et al. Heterogeneous distribution of glutamine synthetase among rat liver parenchymal cells in situ and in primary culture. , 1983, The EMBO journal.
[51] B B Brodie,et al. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. , 1973, The Journal of pharmacology and experimental therapeutics.
[52] B. Brodie,et al. ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. III. CYTOCHROME P-450-MEDIATED COVALENT BINDING IN VITRO , 1973 .
[53] A. Loud. A QUANTITATIVE STEREOLOGICAL DESCRIPTION OF THE ULTRASTRUCTURE OF NORMAL RAT LIVER PARENCHYMAL CELLS , 1968, The Journal of cell biology.
[54] K. Kaneda,et al. Liver microvascular architecture: an insight into the pathophysiology of portal hypertension. , 1999, Seminars in liver disease.
[55] R. Gebhardt. Metabolic zonation of the liver: regulation and implications for liver function. , 1992, Pharmacology & therapeutics.